Cite
Rational Design, Synthesis, Molecular Docking, and Biological Evaluations of New Phenylpiperazine Derivatives of 1,2-Benzothiazine as Potential Anticancer Agents.
MLA
Szczęśniak-Sięga, Berenika M., et al. “Rational Design, Synthesis, Molecular Docking, and Biological Evaluations of New Phenylpiperazine Derivatives of 1,2-Benzothiazine as Potential Anticancer Agents.” Molecules (Basel, Switzerland), vol. 29, no. 18, Sept. 2024. EBSCOhost, https://doi.org/10.3390/molecules29184282.
APA
Szczęśniak-Sięga, B. M., Zaręba, N., Czyżnikowska, Ż., Janek, T., & Kepinska, M. (2024). Rational Design, Synthesis, Molecular Docking, and Biological Evaluations of New Phenylpiperazine Derivatives of 1,2-Benzothiazine as Potential Anticancer Agents. Molecules (Basel, Switzerland), 29(18). https://doi.org/10.3390/molecules29184282
Chicago
Szczęśniak-Sięga, Berenika M, Natalia Zaręba, Żaneta Czyżnikowska, Tomasz Janek, and Marta Kepinska. 2024. “Rational Design, Synthesis, Molecular Docking, and Biological Evaluations of New Phenylpiperazine Derivatives of 1,2-Benzothiazine as Potential Anticancer Agents.” Molecules (Basel, Switzerland) 29 (18). doi:10.3390/molecules29184282.